Nina Teo | Senior Manager, Safety & Risk Management
Alnylam

Nina Teo is a dedicated and experienced Senior Manager in Safety & Risk Management at Alnylam Pharmaceuticals, where she leads and supports pharmacovigilance and risk management activities across clinical development and marketed products. With extensive experience in drug safety, risk management planning, and regulatory compliance, she has contributed to the development and implementation of global safety strategies throughout the product lifecycle, from early clinical development through post-marketing activities. Nina's expertise includes RMPs, aggregate safety reporting, signal management, clinical trial safety oversight, and regulatory submissions. She works cross-functionally with clinical, regulatory, medical, and epidemiology teams to evaluate emerging safety information and support benefit-risk decision-making. She is also actively involved in advancing innovative approaches to risk minimization and patient safety in rare disease and RNAi therapeutic development. An advocate for collaboration and continuous learning, Nina frequently contributes to training, mentoring, and industry discussions focused on pharmacovigilance excellence, patient-centric safety practices, and the evolving role of risk management in drug development.